Guided Therapeutics, Inc. Stock
Stocks
GTHP
US40171F5017
Advanced Medical Equipment & Technology
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2900 USD | 0.00% |
|
+0.28% | -46.30% |
| Jul. 14 | Guided Therapeutics, Inc. Announces New Agreement With Yuanshuo Medical Instruments Corporation | CI |
| Jun. 16 | Guided Therapeutics Files Premarket Approval Application Clinical Report with FDA | CI |
| Market Cap | 28M 24.26M 22.71M 20.72M 39M 2.67B 39.65M 266M 104M 1.34B 105M 103M 4.46B | P/E 2024 |
-3x | P/E 2025 | -12.7x |
|---|---|---|---|---|---|
| Enterprise Value | 30.87M 26.75M 25.05M 22.85M 43M 2.94B 43.73M 294M 115M 1.47B 116M 113M 4.92B | EV / Sales 2024 |
1,649x | EV / Sales 2025 | 64.4x |
| Free-Float |
63.48% | Yield 2024 * |
-
| Yield 2025 | - |
| Current month | -3.33% | ||
| 1 month | -3.33% | ||
| 3 months | +31.82% | ||
| 6 months | -6.45% | ||
| Current year | -46.30% |
| 1 month | 0.24 | 0.3 | |
| Current year | 0.17 | 0.54 | |
| 1 year | 0.15 | 0.54 | |
| 3 years | 0.06 | 0.54 | |
| 5 years | 0.06 | 0.78 | |
| 10 years | 0.02 | 3,200 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Faupel
CEO | Chief Executive Officer | 70 | 2023-03-05 |
| Chief Tech/Sci/R&D Officer | 70 | 2010-12-01 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Faupel
BRD | Director/Board Member | 70 | 2016-11-30 |
John Imhoff
BRD | Director/Board Member | 76 | 2006-04-09 |
Michael James
CHM | Chairman | 67 | 2013-09-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 2/25/26 | Others | Director | 260 | 25.3411% | ||
| 2/25/26 | Option | Chairman | 600,000 | 0.7177% | ||
| 2/25/26 | Fiscal year | Director | 8,477,131 | 10.1402% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | +0.28% | +48.72% | +70.59% | 28M | ||
| +0.80% | +7.16% | +30.89% | +11.30% | 222B | ||
| -0.81% | +6.73% | +4.06% | -18.61% | 147B | ||
| +2.04% | +8.73% | -15.14% | +31.50% | 139B | ||
| +1.54% | +4.57% | -50.04% | +0.60% | 73.13B | ||
| +1.79% | +4.65% | +19.97% | +18.08% | 53.05B | ||
| +1.07% | +1.51% | -13.73% | -16.11% | 50.36B | ||
| +0.54% | +7.53% | +31.14% | +17.98% | 42B | ||
| +0.73% | +4.78% | +48.59% | +42.29% | 40.43B | ||
| -0.04% | +3.79% | -0.10% | +1.86% | 32.95B | ||
| Average | +0.78% | +195.80% | +10.44% | +15.95% | 79.98B | |
| Weighted average by Cap. | +0.84% | +308.17% | +6.65% | +8.58% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 7K 6.07K 5.68K 5.18K 9.75K 668K 9.91K 66.59K 26.09K 334K 26.28K 25.71K 1.11M | 767K 665K 622K 568K 1.07M 73.16M 1.09M 7.3M 2.86M 36.62M 2.88M 2.82M 122M |
| Net income | -2.42M -2.09M -1.96M -1.79M -3.37M -231M -3.42M -22.99M -9.01M -115M -9.08M -8.88M -385M | -3.2M -2.77M -2.59M -2.37M -4.45M -305M -4.53M -30.4M -11.91M -153M -12M -11.74M -509M |
| Net Debt | 1.77M 1.53M 1.44M 1.31M 2.47M 169M 2.51M 16.85M 6.6M 84.55M 6.65M 6.5M 282M | 2.88M 2.49M 2.33M 2.13M 4.01M 274M 4.07M 27.36M 10.72M 137M 10.8M 10.56M 458M |
Employees
3
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-11 | $0.2900 | 0.00% | 4,102 |
- Stock Market
- Stocks
- GTHP Stock
Select your edition
All financial news and data tailored to specific country editions
















